# Impact of Opioid Avoidance Protocol for ACL Reconstruction

> **NCT06340932** · — · COMPLETED · sponsor: **Matthew Varacallo** · enrollment: 32 (actual)

## Conditions studied

- ACL Tear
- Post Operative Pain

## Interventions

- **DEVICE:** Iovera
- **DRUG:** Celecoxib
- **DRUG:** Acetaminophen
- **DRUG:** Oxycodone
- **DRUG:** Tramadol
- **DRUG:** Bupivacaine Hydrochloride
- **DRUG:** Acetaminophen 500Mg Cap

## Key facts

- **NCT ID:** NCT06340932
- **Lead sponsor:** Matthew Varacallo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-27
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06340932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06340932, "Impact of Opioid Avoidance Protocol for ACL Reconstruction". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06340932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*